Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
3Y Annualised
22.29%
-0.73% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
2.34%
-0.73% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
3 years 5 months
5 years 5 months
9 years 7 months
Fund info
Fund size
₹829.63 Cr
Min. SIP amount
₹100
Min. Lumpsum amount
₹1000
Exit load
0.01%
For redemption/switch-out of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption / switch-out of units after 30 days from the date of allotment: Nil
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
ICICI Prudential Nifty Healthcare ETF
2nd
DSP Nifty Healthcare ETF
3rd
PGIM India Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
4th
PGIM India Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
5th
PGIM India Healthcare Fund Direct Growth
90th
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
Fund Managers
About Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is a Equity mutual fund scheme from Aditya Birla Sun Life AMC Ltd. This fund has been in existence for 6 years, having been launched on 2019-07-11. Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has ₹829.63 Cr worth of assets under management (AUM) as of Tue Nov 04 2025. The latest Net Asset Value (NAV) of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth as of Fri Oct 31 2025 is ₹34.16. The fund has an expense ratio of 1.04%, which is medium comparable to most other Equity funds.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth returns for the last 1 year are -0.15%. Since launch, it has delivered 21.40% average annual returns.
The Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth.
- Sun Pharmaceuticals Industries Ltd: 11.17%
 - Apollo Hospitals Enterprise Ltd: 7.59%
 - Cipla Ltd: 6.83%
 - Fortis Healthcare Ltd: 5.58%
 - Abbott India Ltd: 4.57%
 
AMC Information
| Name | Aditya Birla Sun Life AMC Ltd | 
|---|---|
| Founding Date | 2019-07-11 | 
| abslamc.cs@adityabirlacapital.com | |
| Phone | +91 22 4356 8008/ 8000 | 
| Website | https://mutualfund.adityabirlacapital.com/ | 
| Address | Aditya Birla Sun Life AMC Ltd,One World Centre, Tower 1, 17th Floor,Jupiter Mills, Senapati Bapat Marg, Elphinstone Road,Mumbai - 400013 | 
Tax Implications of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess | 
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess | 
Similar Funds from Aditya Birla Sun Life AMC Ltd
AllocationEquity Savings
3Y CAGR
9.73%
expense ratio
0.54%
fund size
₹911.51 Cr
EquityEquity - Consumption
3Y CAGR
15.64%
expense ratio
0.77%
fund size
₹6362.98 Cr
AllocationConservative Allocation
3Y CAGR
10.32%
expense ratio
0.93%
fund size
₹1539.01 Cr
EquityELSS (Tax Savings)
3Y CAGR
15.77%
expense ratio
0.97%
fund size
₹15174.87 Cr
Fixed IncomeMedium Duration
3Y CAGR
6.84%
expense ratio
1.57%
fund size
₹2734.09 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0


